The Real Word Study of Albumin-binding Taxol for Lung Cancer Treatment
NCT03802409 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2019-01-22
Summary
The investigators conduct the real world study to explore the efficacy and safety of Albumin-binding taxol in lung cancer .
Conditions
Sponsors & Collaborators
-
The First Affiliated Hospital of Anhui Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-20
- Primary Completion
- 2020-01-01
- Completion
- 2020-06-30
Countries
- China
Study Locations
More Related Trials
-
Bioinformation Therapy for Lung Cancer
NCT03239171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515 ·Status: COMPLETED
-
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
NCT07250360 ·Status: COMPLETED
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer
NCT04275687 ·Status: UNKNOWN ·Phase: PHASE2
-
Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）
NCT06500312 ·Status: RECRUITING
-
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
NCT06483698 ·Status: RECRUITING
-
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
NCT03427567 ·Status: COMPLETED
-
Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer
NCT02320617 ·Status: UNKNOWN ·Phase: NA
-
Clinical Significance of Computer Aided Image Analysis in Treatment Response Evaluation of Lung Cancer
NCT03954847 ·Status: UNKNOWN
-
Multiplex Analysis of Circulating Tumor DNA
NCT03301961 ·Status: UNKNOWN
-
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
NCT02804100 ·Status: UNKNOWN
-
A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies
NCT03421093 ·Status: COMPLETED
-
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616 ·Status: UNKNOWN
-
Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer
NCT04749407 ·Status: UNKNOWN
-
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
NCT05167604 ·Status: UNKNOWN
-
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
NCT06992583 ·Status: RECRUITING ·Phase: PHASE1
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
NCT06503744 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Cryoablation with Robotic Bronchoscopy System in Patients with Lung Cancer
NCT06832956 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197 ·Status: RECRUITING
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
NCT02407912 ·Status: UNKNOWN ·Phase: NA
-
Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion
NCT02011997 ·Status: UNKNOWN ·Phase: PHASE3
-
Venous Thromboembolism in Advanced Lung Cancer
NCT03581708 ·Status: UNKNOWN